AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS)
$0.0713 0.0013 (1.8571%)
Analysed AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) News Sources
Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
22-06-2026
yahoo.com
Amplia Announces Changes to Board’s Leadership Roles
06-07-2026
yahoo.com
Amplia Announces Appointment of Brett Carter to Board
07-07-2026
yahoo.com
Amplia Announces Publication of New FAK Inhibitor Patent Application
09-07-2026
yahoo.com
Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online
31-07-2026
yahoo.com
Amplia Therapeutics partners with Lilly on lung cancer combination trial
04-08-2026
proactiveinvestors.com
Amplia Signs Collaboration Agreement With Lilly, Evaluating Narmafotinib Plus Lilly’s Kras G12C Inhibitor, Olomorasib, in Non-small Cell Lung Cancer
04-08-2026
yahoo.com
Life Sciences Virtual Investor Forum Agenda Announced
14-09-2026
yahoo.com
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
18-09-2026
yahoo.com
INNMF Advancing Cancer Treatments
05-06-2026
yahoo.com
What is the current price of AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS)?
The current price of AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) is $0.0713.
AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) since the previous trading day is $0.0013.
AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) since the previous trading day is 1.8571%.
What is the most recent average sentiment score for AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS)?
The most recent average sentiment score for AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) is 78 out of 100.
What is the most recent average sentiment for AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS)?
The most recent sentiment for AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS) is .
SEC-8K** Filing Available For AMPLIA THERAPEUTICS LTD (INNMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.